Pure Global Cannabis
TSXV:PURE
Science-based Wellness
Science-based Wellness
Pure Global Cannabis Inc. (TSXV:PURE; OTC: PRCNF; FRA:1QS) is a vertically-integrated and growth-oriented cannabis company that is focused on producing high-quality pharmaceutical-grade cannabis for the global medical and recreational cannabis markets. With a global focus in mind, Pure Global has facilities in Canada and also has its sights on the EU and Latin American markets. The company is primarily focused on creating a cannabis product that enhances the well-being of consumers and they have deployed a four point strategy to ensure that they are addressing consumer needs.
According to a report released by Grand View Research, the global cannabis market is expected to reach $146.4 billion by 2025. The industry’s growth is primarily driven by the advancements being made in the medical cannabis market. Doctors are less likely to prescribe smoking to their patients and the focus of the market is turning to cannabis concentrates.
Pure Global’s Canadian facility is strategically located in Brampton, Ontario and provides the company with easy access to Toronto’s downtown core and international airport. The facility is currently undergoing Phase 2 of construction, which is focused on developing the company’s vertical multi-ponic cultivation facility, the first of its kind in Canada. Once Phase 2 construction is complete, it will be able to produce approximately 4,000 kilograms of cannabis per year.
Pure Global’s management team is led by experienced pharma, horticultural, consumer packaged goods and supply chain industry specialists. The company’s management team notably owns 21 percent of the company’s shares.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.